Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;180(5-6):305-15.
doi: 10.1007/s11046-015-9925-y. Epub 2015 Jul 16.

Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole

Affiliations

Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole

André Moreira et al. Mycopathologia. 2015 Dec.

Abstract

Candida bracarensis is an uncommon Candida species found during an epidemiological study of candidiasis performed in Braga, Portugal. Initially, it was identified as C. glabrata, but recently detailed analyses pointed out their differences. So, little information is still available about C. bracarensis virulence factors and antifungal susceptibilities. Therefore, the main goal of this work is to evaluate the ability of C. bracarensis to form biofilms, to produce hydrolytic enzymes (proteases, phospholipases and hemolysins), as well as its susceptibility to amphotericin B and fluconazole. It was shown, for the first time, that all C. bracarensis strains were able to form biofilms and display proteinase and hemolytic activities. Moreover, although planktonic cells presented antifungal susceptibility, amphotericin B and fluconazole were unable to inhibit biofilm formation and eradicate pre-formed biofilms. Due to the propensity of C. bracarensis to display antifungal resistance and virulence attributes, the control of these emerging pathogens is recommended.

Keywords: Amphotericin B; Antifungal resistance; Candida bracarensis; Fluconazole; Virulence factors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Oral Dis. 2014 May;20(4):329-44 - PubMed
    1. J Med Microbiol. 2005 Jun;54(Pt 6):583-93 - PubMed
    1. Clin Microbiol Rev. 2001 Apr;14(2):398-429 - PubMed
    1. Clin Infect Dis. 1997 Jun;24(6):1122-8 - PubMed
    1. J Clin Microbiol. 2009 Apr;47(4):1216-7 - PubMed

Publication types

LinkOut - more resources